These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24894841)

  • 1. A prospective study of serum metabolites and colorectal cancer risk.
    Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
    Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer.
    Guertin KA; Loftfield E; Boca SM; Sampson JN; Moore SC; Xiao Q; Huang WY; Xiong X; Freedman ND; Cross AJ; Sinha R
    Am J Clin Nutr; 2015 May; 101(5):1000-11. PubMed ID: 25762808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites of tobacco smoking and colorectal cancer risk.
    Cross AJ; Boca S; Freedman ND; Caporaso NE; Huang WY; Sinha R; Sampson JN; Moore SC
    Carcinogenesis; 2014 Jul; 35(7):1516-22. PubMed ID: 24648381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of blood metabolites associated with colorectal cancer risk.
    Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W
    Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.
    Troche JR; Mayne ST; Freedman ND; Shebl FM; Guertin KA; Cross AJ; Abnet CC
    PLoS One; 2016; 11(3):e0150962. PubMed ID: 26967509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
    Guertin KA; Moore SC; Sampson JN; Huang WY; Xiao Q; Stolzenberg-Solomon RZ; Sinha R; Cross AJ
    Am J Clin Nutr; 2014 Jul; 100(1):208-17. PubMed ID: 24740205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Investigation of Serum Metabolites, Coffee Drinking, Liver Cancer Incidence, and Liver Disease Mortality.
    Loftfield E; Rothwell JA; Sinha R; Keski-Rahkonen P; Robinot N; Albanes D; Weinstein SJ; Derkach A; Sampson J; Scalbert A; Freedman ND
    J Natl Cancer Inst; 2020 Mar; 112(3):286-294. PubMed ID: 31168595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
    Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel serum metabolomics-based diagnostic approach for colorectal cancer.
    Nishiumi S; Kobayashi T; Ikeda A; Yoshie T; Kibi M; Izumi Y; Okuno T; Hayashi N; Kawano S; Takenawa T; Azuma T; Yoshida M
    PLoS One; 2012; 7(7):e40459. PubMed ID: 22792336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen metabolism and risk of breast cancer in postmenopausal women.
    Fuhrman BJ; Schairer C; Gail MH; Boyd-Morin J; Xu X; Sue LY; Buys SS; Isaacs C; Keefer LK; Veenstra TD; Berg CD; Hoover RN; Ziegler RG
    J Natl Cancer Inst; 2012 Feb; 104(4):326-39. PubMed ID: 22232133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional metabolomics and breast cancer risk in a prospective study.
    Playdon MC; Ziegler RG; Sampson JN; Stolzenberg-Solomon R; Thompson HJ; Irwin ML; Mayne ST; Hoover RN; Moore SC
    Am J Clin Nutr; 2017 Aug; 106(2):637-649. PubMed ID: 28659298
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
    Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
    Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Kunzmann AT; Coleman HG; Huang WY; Kitahara CM; Cantwell MM; Berndt SI
    Am J Clin Nutr; 2015 Oct; 102(4):881-90. PubMed ID: 26269366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.